BETAAccess all features while we're in beta! Some features may become paid later.Got feedback? Reach us 👉

Loading OGEN charts…

Search ticker or company⌘K

OGEN

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

OGEN · Oragenics Inc. fundamentals · vpside

vpside

⌘K

OGENMarket cap $2M/Last filing 10-Q · 13 Aug 2026/OGENMarket cap $2M/Last filing 10-Q · 13 Aug 2026/OGENMarket cap $2M/Last filing 10-Q · 13 Aug 2026/OGENMarket cap $2M/Last filing 10-Q · 13 Aug 2026/

Filings synced 13:22 · Prices: prior close 30 Oct

OGEN

Oragenics Inc.

NYSE · Pharmaceutical preparations (SIC 2834) · FY ends 31 Dec

01Multicharts 02Comparables 03Price target

Add a metric37 metrics

Revenue, quarterly

$100000$50000$0

vpside.com

Q1 ’19Q2 ’20Q3 ’21Q3 ’22Q4 ’23

Company filings · 10-K filed 14 Mar 2025 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

71.7%+43.5 pp year on year

80%60%40%20%0%

vpside.com

Q4 ’11Q1 ’13Q2 ’14Q2 ’15Q3 ’16

Company filings · 10-Q filed 14 Nov 2016 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$4M+95.8% year on year

$30M$20M$10M$0

vpside.com

Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26

Company filings · 10-Q filed 13 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$15M

$10M$0−$10M−$20M

vpside.com

Q1 ’18Q2 ’19Q3 ’20Q3 ’21Q4 ’22

Company filings · 10-K filed 29 Mar 2024 · TTM = last four quartersvpside.com

Chart 05 is empty

Chart 06 is empty

Fundamentals: company filings · Q4 = full year − nine months · TTM = last four quarters